1.130USD-2.59%Mkt Cap: 49.51M USDP/E: —Last update: 2026-05-26
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiov…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap49.51M USD
Enterprise Value11.66M USD
Revenue (TTM)12.29M USD
Gross Profit6.60M USD
Net Income (TTM)53.38M USD
Revenue/Share0.2970 USD
Last Price1.130 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.09
PEG—
EV/EBITDA-0.68
EV/Revenue0.95
P/S4.32
P/B1.85
EPS (TTM)-0.65
EPS (Forward)-1.10
52W Range
0.500029% of range2.640
52W High2.640 USD
52W Low0.5000 USD
Profitability
Gross Margin53.66%
Oper. Margin-167.87%
EBITDA Margin-139.88%
Profit Margin434.23%
ROE192.90%
ROA85.61%
Growth
Revenue Growth16.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.81M USD
CapEx (TTM)1.88M USD
FCF Margin-204.22%
FCF Yield-50.70%
Net Debt-32.41M USD
Net Debt/EBITDA1.88
Balance Sheet
Debt/Equity0.14
Current Ratio2.22
Quick Ratio1.51
Book Value/Sh0.6470 USD
Cash/Share0.8500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.44.21M
Float24.89M
Insiders3.56%
Institutions45.72%
Short Interest
Short Ratio1.8d
Short % Float0.33%
Short % Out.0.27%
Shares Short126.20K
Short (prev mo.)128.63K
Technical
SMA 501.087 (+3.9%)
SMA 2001.076 (+5.0%)
Beta0.76
S&P 52W Chg28.31%
Avg Vol (30d)123.40K
Avg Vol (10d)139.16K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—